Skip to content
Search

Latest Stories

Formula milk companies use exploitative tactics to undermine breastfeeding: Lancet series

Globally, only around 1 in 2 newborns are put to the breast within the first hour of life while fewer than half of infants under six months are exclusively breastfed, as per WHO recommendations.

Formula milk companies use exploitative tactics to undermine breastfeeding: Lancet series

The formula milk industry's marketing tactics are exploitative and undermine breastfeeding, according to a three-paper series published in The Lancet which calls for urgent clampdowns to tackle misleading claims and political interference.

The papers suggest that industry influence - which includes lobbying against vital breastfeeding support measures - seriously jeopardises the health and rights of women and children.


"This new research highlights the vast economic and political power of the big formula milk companies, as well as serious public policy failures that prevent millions of women from breastfeeding their children," said Professor Nigel Rollins, a scientist at the World Health Organization (WHO) and author of a paper on formula milk marketing.

"Actions are needed across different areas of society to better support mothers to breastfeed for as long as they want, alongside efforts to tackle exploitative formula milk marketing once and for all," Rollins said in a statement.

Given the significant contributions of breastfeeding to people's health, the Lancet series recommends much greater support for breastfeeding within healthcare and social protection systems -- including guaranteeing sufficient paid maternity leave.

Globally, only around 1 in 2 newborns are put to the breast within the first hour of life while fewer than half of infants under six months are exclusively breastfed, as per WHO recommendations.

Currently, around 650 million women lack adequate maternity protections, the papers note.

Misleading marketing claims and strategic lobbying from the dairy and formula milk industries further add to the challenges parents face, by increasing anxiety around breastfeeding and infant care.

The World Health Assembly developed the International Code of Marketing of Breast-milk Substitutes (the Code) in 1981 and several subsequent resolutions.

However, intensive marketing of infant formula continues largely unabated, with sales from these products now approaching USD 55 billion a year, WHO said in a statement.

The first paper in the Lancet series documents how misleading marketing claims directly exploit parental anxieties around normal infant behaviours, suggesting that commercial milk products alleviate fussiness or crying, for instance, that they help with colic, or prolong night-time sleep.

The authors stress that, when mothers are appropriately supported, such parental concerns can be managed successfully with exclusive breastfeeding.

"The formula milk industry uses poor science to suggest, with little supporting evidence, that their products are solutions to common infant health and developmental challenges," said Professor Linda Richter from the University of the Witwatersrand, South Africa.

"This marketing technique clearly violates the 1981 Code, which says labels should not idealise the use of formula to sell more product,” Richter said.

The series explains how formula milk marketing exploits the lack of support for breastfeeding by governments and society, while misusing gender politics to sell its products.

This includes framing breastfeeding advocacy as a moralistic judgment, while presenting milk formula as a convenient and empowering solution for working mothers. The series further draws attention to the power of the milk formula industry to influence national political decisions and interfere with international regulatory processes.

In particular, the dairy and formula milk industries have established a network of unaccountable trade associations and front groups that lobby against policy measures to protect breastfeeding or control the quality of infant formula.

In addition to ending exploitative marketing tactics and industry influence, broader actions across workplaces, healthcare, governments, and communities are needed to effectively support women who want to breastfeed so that it becomes a collective societal responsibility, rather than placing the onus on women, the authors said.

The authors particularly highlight the need to ensure women have adequate maternity protections assured by law, including paid maternity leave that aligns, at minimum, with the WHO-recommended duration of six months for exclusive breastfeeding.

- PTI

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less